2-[3-[(Hydroxyimino)methyl]-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylic Acid Ethyl Ester, is an impurity of Febuxostat (F229000), an Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.
SKU | RCLST019692 |
---|---|
CAS number | 1271738-74-9 |
Molecular Formula | C18H22N2O4S |
Catalog Number | RCLST019692 |
Chemical Name | 2-[3-[(Hydroxyimino)methyl]-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylic Acid Ethyl Ester |
Molecular Weight | 362.44 |
Solubility | Dichloromethane; Ethyl Acetate |
Stability | No Data Available |
Appearance | Yellow Solid |
Storage Condition | No Data Available |